Cargando…
Sclerostin Inhibition: A Novel Target for the Treatment of Postmenopausal Osteoporosis
Osteoporosis, a widespread skeletal disorder with a substantial economic load, is characterized by increased porosity of the bones resulting in vulnerability to fractures. When activated, the canonical Wnt signaling pathway results in osteoblastogenesis and bone formation. A Wnt ligand forms a compl...
Autores principales: | Aditya, Suruchi, Rattan, Aditya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849148/ https://www.ncbi.nlm.nih.gov/pubmed/35264832 http://dx.doi.org/10.4103/jmh.JMH_106_20 |
Ejemplares similares
-
Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis
por: Shah, Arti D, et al.
Publicado: (2015) -
Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016) -
Advances in CGRP Monoclonal Antibodies as Migraine Therapy: A Narrative Review
por: Aditya, Suruchi, et al.
Publicado: (2023) -
Vismodegib: A smoothened inhibitor for the treatment of advanced basal cell carcinoma
por: Aditya, Suruchi, et al.
Publicado: (2013) -
Vaptans: A new option in the management of hyponatremia
por: Aditya, Suruchi, et al.
Publicado: (2012)